glp 1 zealthy Expands Insurance Coordination for GLP-1 Weight-Loss Medications 6c802606-group-241-2.svg
Description
Most patients begin seeing weight loss within the first 46 weeks, especially when combined with simple dietary changes
Zepbound Offers Unique Health Benefits : Obstructive Sleep Apnea (OSA): Tirzepatide (Zepbound) is the only medication in its class FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity
No medical or veterinary claims are made
Customer support leans on chatbots, which can be frustrating
Insulin and insulin-like growth factor 1 (IGF-1) are thought to play a role in promoting this condition, as their receptors are present on keratinocytes and fibroblasts
Gromada J, Franklin I, Wollheim CB
